Abstract
have only been just for sc applications. Here, effects resulting from oral application 48 were qualitatively described evaluated for their applicability. The UWW and 49 expression of proliferation-associated genes were increased following both po and sc 50 treatment with PPT. DPN did not exert an increase of the UWW, but a significant 51 decrease of proliferation-associated gene and protein expression. Additionally, a 52 substantial hypoplasia was detectable in the uterine cross sections of DPN-treated 53 mice. On the other hand, the phytoestrogen genistein (sc 10 mg/ kg BW; po 70 54 mg/ kg BW) did not cause detectable uterotrophic responses or large changes of 55 uterine and ovarian gene expression profiles under the applied experimental 56
conditions, but significantly reduced the elevated gonadotropin levels of ArKO mice. 57
In summary, we showed the utility of ArKO mice to detect ER-specific effects, in 58 particular those of PPT and DPN also when applied orally. 59
Page 6 of 39 A c c e p t e d M a n u s c r i p t 6 controlled conditions of temperature (20 ±1 °C, relative humidity 50 -70 %) and 160 illumination (12 h light / 12 h dark) and had free access to diet and water. The 161 company Altromin (Lage, Germany) produced the standard and the experimental 162 diets containing the test substances. An isoflavone-free diet with a 17% protein-163 content based on milk-protein was used as standard chow. All animal handling and 164 experimental conditions were conducted in accordance to the principles and 165 procedures of the German Federal Law for Animal Welfare and were approved by 166 the Animal Care and Use Committee of the Technische Universität Dresden. 167
Treatment and experimental design 168
The substances were administered either per os (po, orally) via diet or by 169 subcutaneous (sc) injection according to a three-day uterotrophic assay. The ArKO 170 mice of an average age of 8 weeks were randomly divided into experimental groups 171 and the control group (designated as CO) (n = 5-8). Moreover, a group of female 172 wild-type littermates (WT; n = 6) with the same genetic background (C57BL/6J) were 173 included in the experimental setup as a reference group for physiologically normal 174 mice. Mice were maintained on isoflavone-free diet, because it has been recently 175 shown from our laboratory team, that long-term intake of dietary phytoestrogens 176 influences the estrogenic responses in the organism (Moller et al., 2009) . 177
The substance administrations were organized as follows. The mice of the po groups 178 had 72 hours access to the experimental chow and the mice of the sc groups were 179 injected at three time points (0 h, 24 h and 48 h). Subcutaneous injections consisted 180 of castor oil with the substances pre-dissolved in DMSO. The mice of the ArKO 181 control group (CO) and WT group were injected with the carrier solution (DMSO in 182 castor oil) only. For the oral substitution, the substances were blended with the 183 standard diet by the manufacturer in concentrations of 0.5 mg / kg diet (EE) and 50 184 mg / kg diet (PPT, DPN). The average amount of chow taken up by the mice was 185 about 10 % of their bodyweight (BW) per day (data not shown). Therefore, the oral 186 exposure was estimated to 0.05 mg / kg BW / d for EE and 5.0 mg / kg BW / d for the 187 ER-agonists (PPT, DPN). The GEN-rich diet, containing 700 µg / g GEN, was 188 custom-made by LC Laboratories (Woburn, USA). concentrations. Blood samples were taken post-mortem and allowed to clot before 201 centrifugation (4 min at 3,000 x g) for serum preparation. Serum samples were 202 diluted 1:10 and 1:100 for LH and FSH, respectively, in PBS buffer (pH 7.0 -7.2) 203 before proceeding according to manufacturer's protocol. 204
Gene expression analyses

205
Total RNA was isolated from the frozen tissues using the RNeasy™ Mini Plus Kit 206 (Qiagen) according to the manufacturer's instruction. Three microgram of total RNA 207 of uterine samples and 0.6 µg ovarian samples were digested with DNase I 208 (Promega) to eliminate DNA residues, which was checked by real-time PCR. MMLV 209
Reverse Transcriptase (Promega) and oligo-d(T) 18 primer (MWG; Ebersberg, 210 Germany) were used for cDNA synthesis. The resulting cDNA was amplified by real-211 time PCR in the iCycler (Biorad) using Platinum ® Taq DNA polymerase (Invitrogen 212 Life Technologies, Karlsruhe, Germany) and the Sybrgreen ® detection system 213 (Sigma). All PCR reactions were conducted in triplicates and repeated three times. 214
Relative gene expression levels of target genes were corrected for the expression of 215 the internal reference gene (RPS18; ribosomal protein S18) ( 
Oligonucleotides used as primers for real-time PCR
221
Based on the DNA sequences available at the UCSC Genome Browser database 222 (http://genome.ucsc.edu/), the following primer pairs were designed to specifically 223 amplify the cDNAs of interest (see Table 2 ). The primer selection was accomplished 224
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A c c e p t e d M a n u s c r i p t 8 using the software Primer3 (Whitehead Institute for Biomedical Research Cambridge, 225 MA, USA) upon specific parameters. The specificity of the primers was confirmed 226 with the Blat-and in silico PCR tools provided at the UCSC Genome Browser 227 website. All oligonucleotides were synthesized by Eurofins MWG Operon (Ebersberg, 228 Germany). Sequences and amplicon sizes of the primer pairs are listed in Table 2 . 229
The efficiency of every PCR reaction was optimized for primer-and magnesium 230 chloride concentrations. All PCR products exhibited a single peak in the melting 231 curve analysis and were identified upon their appropriate amplicon sizes by gel 232 electrophoresis on ethidium bromide agarose gels. 233
Histological analysis 234
Formalin-fixed uterine and ovarian tissues of the CO and the experimental groups 235 were dehydrated and processed for paraffin embedding. Tissue cross sections 236 (3 µm) were processed for hematoxylin-eosin staining to evaluate the 237 histopathological changes of the tissues. The height of the uterine epithelia was 238 determined using a microscope micrometer scale and the program ImageJ 239 
Results
263
Uterine wet weight and epithelia height
264
The uterine wet weights (UWW) and epithelia heights were the main physiological 265 endpoints utilized for the assessment of estrogenicity. The UWW were normalized 266 against the bodyweight and calculated by fold change relative to the ArKO carrier-267 treated control group (CO; 1 ± 0.4 fold) to obtain a more precise evaluation and a 268 better comparability. 269
As depicted in figure 1 , the relative UWW of the WT littermates were 3.7 fold higher 270 (p < 0.01) than those of CO mice. Irrespective of the route of administration, the 271 treatment with 17α-ethynylestradiol (EE) increased the UWW of ArKO mice even 272 above the WT level (po 7.1 ± 2.4 fold and sc 6.9 ± 1.7 fold vs. CO; both p < 0.001). 273
Analyzing the effects of the ERα-agonist PPT, the oral administration caused a 274 stronger weight increase (4.1 ± 0.9 fold vs. CO; p < 0.001) than the sc injection 275 (2.2 ± 0.7 fold vs. CO; p < 0.01). Neither genistein (GEN; po 0.9 ± 0.2 and sc 276 1.1 ± 0.4) nor ERβ-agonist (DPN; po 1.3 ± 0.6; sc 0.8 ± 0.2) substitution resulted in 277 significant changes of UWW compared to CO. 278
In addition, the morphologies of uterine epithelia for all treatment groups are depicted 279 in figure 2. EE increased the uterine epithelial heights following both administration 280 routes (po 1.5 ± 0.3 fold and sc 1.5 ± 0.2 fold vs. CO), which was the same for per os 281 administration of PPT (1.5 ± 0.2 fold vs. CO). In the case of sc administration of PPT, 282 the heights of the uterine epithelia did not change versus CO (0.9 ± 0.1 fold vs. CO) 283 which was similar in the GEN-as well as the DPN-group, whereby it was noticeable 284 that uteri of DPN-treated mice showed visible changes in overall size and 285
morphology (figure 2 F & G). 286
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Serum gonadotropin levels
287
In ArKO mice, serum LH (luteinizing hormone) and FSH (follicle-stimulating hormone) 288 were significantly elevated compared to WT littermates (table 3). The oral 289 administration of the tested substances led to a significant decrease of the LH and 290 FSH levels, whereas subcutaneous injections engendered a much weaker effect, 291 except for DPN. The subcutaneous effects on the gonadotropin levels were less 292 obvious in the PPT group and not observable for EE. Overall, DPN had only weak 293 but significant influences on the LH and FSH levels. Genistein caused a significant 294 reduction (i.e. back to WT level) of both LH and FSH serum levels following both 295 administration paths, 296
Uterine gene and protein expression 297
To investigate the molecular mechanisms regarding the sensitivity of ArKO mice uteri 298 to exogenous estrogens, we performed real-time PCR of either genes, related to 299 proliferation or sensitive estrogen-responsive genes. 300
Although there were obvious differences of relative UWW between CO and WT 301 (figure 1) no significant differences of the proliferation index genes, PCNA and MKI67 302 which are shown to be related to male-like structures visible in ArKO ovaries (Britt et 380 al., 2004) . In the present study, the expression of some of these nuclear transcription 381 factors were examined by real-time PCR: Sf-1 (steroidogenic factor 1) and the 382 related LRH-1 (liver receptor homologue 1), as well as DAX-1 (the dosage-sensitive 383 sex reversal adrenal hypoplasia congenital critical region on the X-chromosome 384 gene 1) and SOX-9. In the ovaries of CO mice, the transcription levels of all these 385 genes were very close to detection limit. Regarding DAX-1 and SOX-9, no evaluation 386
Page 13 of 39 A c c e p t e d M a n u s c r i p t 13 of expression profiles was possible because of very weak gene expressions (data not 387 shown). Nevertheless, in WT ovaries the gene expression levels of all analyzed 388 genes were obviously higher than in CO or treated ArKO mice ovaries. However, SF-389 1 was significantly up-regulated (p < 0.05 vs. CO) in all per os groups, except for 390 we decided to use 10-fold higher doses because initially we expected oral effects of 417 PPT and DPN to be weaker due to metabolic aspects. Both were applied at doses of 418 0.5 mg / kg BW for sc administration and 5 mg / kg BW for per os administration at 419
GEN (figure 8A
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Uterine responses of ArKO mice 430
In this study, the highly sensitive regulations of uterine and ovarian physiology and 431 molecular parameters of ArKO mice were not studied within the light of reproductive 432 biology, but as parameters for characterization of the ER subtype-specific 433 substances. In particular, the uterus of estrogen-deprived animals is known to 434 sensitively react upon activation of ERα signaling by triggering growth and 435
proliferation (Diel et al., 2004). 436
In accordance with other groups, we observed that uteri of carrier-treated ArKO mice 437 were dramatically diminished in uterine size, weight and volume compared to wt 438 siblings (Fisher et al., 1998 , Toda et al., 2001 ). Here, this estrogen-deprivation was 439 mainly observed on dramatically decreased uterine wet weights (UWW), but also the 440 epithelial heights were reduced. As expected, EE and PPT substitution increased 441 both physiological parameters, whereby UWW reactions were more sensitive than 442 epithelial heights, which differs from ovariectomized rats (Diel et al., 2002) . 443
On the other hand, no significant alterations of UWW or epithelial heights could be 444 observed following DPN and GEN administration. Moreover, the overall morphology 445 of uteri cross sections of the DPN groups was observably hypoplastic. 
Gene expression profiles of ArKO uteri 469
We supported and specified the physiological data by analyzing gene expression 470 levels of two marker genes for proliferation, PCNA and MKI67. Interestingly, in CO 471 and WT uteri levels of both were on an equal level, even though the UWW were 472 disparate. This could indicate an equilibrium state without exogenous induction. immature in vivo models, progesterone production is not compromised. 549
Gene expression profiles of ArKO ovaries 550
Ovaries were examined because they represent a target organ with high ERβ 551 distribution (Drummond et al., 2002) and may be useful to evaluate in particular the 552 ERβ-specific actions of the tested substances. Unfortunately, the measured ovarian 553 weights as well as the morphological analysis of ovarian cross sections were not 554 convincing enough for a conclusive comparison of substance responses (data not 555
Page 18 of 39 A c c e p t e d M a n u s c r i p t 18 shown). Probably, the three-day treatment period was not sufficient to abundantly 556 influence ovarian phenotypes. Nevertheless, we used the ovaries of differentially 557 treated ArKO mice to isolate RNA and analyze estrogen-responsiveness by gene 558 expression analysis. In the ovaries, ESR2 was highly expressed but hardly 559 influenced by the treatments. Although, there were no transcripts of ESR1 detectable 560 in ovaries of CO, ESR1 transcription was switched on following application of the 561 substances, irrespective of the type of ligand. This shows the capacity of ArKO 562 ovaries to respond directly via both ERs upon stimulation. 563
Additionally, we were examining the ovarian proliferation and differentiation status. 564
Thereby, the LH-receptor status served as indicator for differentiation, because of its 565 association with improved morphology (Britt et al., 2004 ) and its expression 566 described to increase in antral follicles (Nimrod et al., 1977) . The WT ovaries 567 displayed the most differentiated profile according to high LHR gene expression, 568 whereas in CO the lowest levels were detected. None of the treatments led to 569 significant alterations compared to CO level. There could also be a connection to 570 serum LH levels which are known to decrease LHR expression (Nimrod et al., 1977 , 571 Richards, 1975 . 572
Furthermore, we investigated the ovarian proliferation status by analyzing the 573 expression levels of PCNA. Identical to the findings in the uterus, CO and WT level 574 did not significantly differ in their profile. Hence, significant induction of proliferation 575 was detected following EE and PPT (po) and in tendency DPN administration. 576
According to Britt et al., ovarian weights were dependant on specific treatment, which 577 should be taken into account in further studies (Britt et al., 2005 , Britt et al., 2004 . 578
Since previous studies described the emergence of male somatic cells in the ovaries 579 of estrogen-depleted mice and described an improvement by administration of 580 estrogenic substances (Britt et al., 2004 , Couse et al., 1999 , we used these 581 steroidogenic marker genes to evaluate their expression pattern in specifically 582 treated ArKO mice. All these genes encode for nuclear transcription factors, which 583 are naturally involved in the gonadal development. A high expression of Sox9 and 584 changes of up-and down-stream regulating factors (SF-1, LRH-1 and DAX-1) are 585 responsible for the male-like phenotype of the gonads (Britt et al., 2004) . In CO, the 586 gene expression level of all of these transcription factors were very close to the 587 detection limit. In our experimental setup, these genes, which were regulated by Britt 588 and colleagues, were not abundantly influenced in our three-day assay. Perhaps, the Data is normalized against the CO group (black horizontal line) and presented as mean ± SD. Statistical analyses were performed using the Student's t-test, p < 0.05 *. 
